Management of Uterine Arteriovenous Malformation: Uterine Artery Embolization followed by Gonadotropin-Releasing Hormone Agonist

被引：1
|
作者：
Li, He [1 ]
Yi, Xiaofang [2 ,3 ]
机构：
[1] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai, Peoples R China
[2] Fudan Univ, Dept Gynecol Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
来源：
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY | 2021年 / 28卷 / 05期
关键词：
LAPAROSCOPIC BIPOLAR COAGULATION;
D O I：
10.1016/j.jmig.2020.12.033
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：936 / 937
页数：2
相关论文
共 50 条
  • [41] Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: Effects on bone metabolism
    Palomba, S
    Orio, F
    Morelli, M
    Russo, T
    Pellicano, M
    Nappi, C
    Mastrantonio, P
    Lombardi, G
    Colao, A
    Zullo, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10): : 4476 - 4481
  • [42] Embolization of uterine arteriovenous malformation for treatment of menorrhagia
    Sapna Patel
    Sushma Potti
    David Jaspan
    Vani Dandolu
    Archives of Gynecology and Obstetrics, 2009, 279 : 229 - 232
  • [43] Embolization of uterine arteriovenous malformation for treatment of menorrhagia
    Patel, Sapna
    Potti, Sushma
    Jaspan, David
    Dandolu, Vani
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 279 (02) : 229 - 232
  • [44] GONADOTROPIN-RELEASING HORMONE SPECIFIC BINDING-SITES IN UTERINE LEIOMYOMATA
    WIZNITZER, A
    MARBACH, M
    HAZUM, E
    INSLER, V
    SHARONI, Y
    LEVY, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (03) : 1326 - 1331
  • [45] Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis
    Donnez, Olivier
    Donnez, Jacques
    FERTILITY AND STERILITY, 2020, 114 (03) : 640 - 645
  • [46] Gonadotropin-releasing hormone antagonists - Implications for oocyte quality and uterine receptivity
    Gordon, K
    HUMAN FERTILITY AND REPRODUCTION: THE OOCYTE, THE EMBRYO, AND THE UTERUS, 2001, 943 : 49 - 54
  • [47] Therapeutic effect and underlying mechanism of Gonadotropin-releasing hormone in uterine fibroids
    Gong, Y. F.
    Han, W.
    Cui, Y.
    Li, L. Y.
    Lu, L. Y.
    Ren, C. N.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (04): : 1437 - 1443
  • [48] Uterine leiomyomata and sterility: Therapy with gonadotropin-releasing hormone agonists and leiomyomectomy
    Kuhlmann, M
    Gartner, A
    Schindler, EM
    Regidor, PA
    Buhler, K
    Schindler, AE
    GYNECOLOGICAL ENDOCRINOLOGY, 1997, 11 (03) : 169 - 174
  • [49] GONADOTROPIN-RELEASING-HORMONE AGONIST ANALOGS IN THE TREATMENT OF UTERINE LEIOMYOMAS
    ROCK, JA
    JOURNAL OF GYNECOLOGIC SURGERY, 1991, 7 (03) : 147 - 153
  • [50] Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure
    Bozzini, N
    Rodrigues, CJ
    Petti, DA
    Bevilacqua, RG
    Gonçalves, SP
    Pinotti, JA
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (04) : 330 - 334
12345